Growth and Tolerance of Term Infants Fed Formula With Probiotic Lactobacillus reuteri

Clinical Pediatrics
Pamela L CekolaJose M Saavedra

Abstract

Lactobacillus reuteri has been studied for its safety and beneficial effects in infants. This study assessed growth of infants fed a partially hydrolyzed whey formula with L reuteri. Healthy term infants were randomized to 1 of 2 formulas (partially hydrolyzed whey formula with (PRO) or without (CON) L reuteri from 14 to 112 days of age. Anthropometric measures were assessed at 14, 28, 56, 84, and 112 days of age. Tolerance records were completed 2 days prior to each visit. A total of 122 subjects completed study per protocol (60 PRO, 62 CON). No differences were seen in daily weight gain, length, or head circumference. Overall, between groups, there were no significant differences in formula intake, stool frequency, color, consistency, flatulence, frequency of spit-up/vomiting, mood, sleep, or incidence of adverse events. Infants fed probiotic formula had similar growth to infants fed control formula. Both formulas were well tolerated.

References

Dec 1, 1988·The Journal of Pediatrics·D J MooreG P Davidson
Mar 22, 2002·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·D KanabarP Clayton
Oct 6, 2005·Journal of Pediatric Gastroenterology and Nutrition·Eamonn ConnollyBengt Björkstén
Sep 5, 2006·Pediatrics·Melvin B Heyman, UNKNOWN Committee on Nutrition
Oct 13, 2006·Journal of the American College of Nutrition·Zvi Weizman, Ahmed Alsheikh
Jan 18, 2012·JPEN. Journal of Parenteral and Enteral Nutrition·Hannah D HolscherKelly A Tappenden
Jan 18, 2012·JPEN. Journal of Parenteral and Enteral Nutrition·Hannah D HolscherKelly A Tappenden
May 14, 2014·European Journal of Pediatrics·Magdalena Urbańska, Hania Szajewska

❮ Previous
Next ❯

Citations

Jan 13, 2017·Gut Microbes·Luis VitettaSean Hall
Feb 11, 2016·Clinical Medicine Insights. Pediatrics·Mark CorkinsJosé M Saavedra
Mar 14, 2019·The Cochrane Database of Systematic Reviews·Teck Guan OngAnthony K Akobeng
Jul 31, 2020·Nutrients·Elisabet Navarro-TapiaVicente Andreu-Fernández
May 5, 2018·Frontiers in Microbiology·Qinghui MuXin M Luo

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01476397

Software Mentioned

HealthWatch Pro
SAS

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.